Floatz logo

Etoposide

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Weill Medical College of Cornell UniversitySmall moleculePhase 2Active
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
67/ 100
Competitive Position
89/ 100

Competitive context

202 Active assets in the Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cohort.

Asset / SponsorPhaseRating
Chlorambucil
Ascentage Pharma Group Inc.
Phase 4BBB
Lisaftoclax
Henan Cancer Hospital
Phase 3BBB
Prednisone
AstraZeneca
Phase 3BBB
Irinotecan
IGM Biosciences, Inc.
Phase 2BBB
Rituximab
M.D. Anderson Cancer Center
Phase 4BB

View all 50 →

Same molecule, other indications

Etoposide is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →